Egrifta

Tesamorelin

7.5 High risk

Egrifta & Peripheral swelling

11.2%

of users reported Peripheral swelling

50.0%

also reported Death

76.2%

are men

Most common medical consequences

Death
50.0%
Severe reaction
50.0%

Have you experienced any negative side effects from this medication?

Egrifta: general information

Most common side effects (25)

Most commonly affected ages

40 - 49 years
9.1%
50 - 59 years
81.8%
60 - 69 years
9.1%